CMF
RXST icon

Counterpoint Mutual Funds’s RxSight RXST Stock Holding History

Counterpoint Mutual Funds’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,647
Closed -$219K – 366
2024
Q2 		$219K Sell
3,647
-9,926
-73% -$567K 0.05% 154
2024
Q1 		$700K Buy
13,573
+6,883
+103% +$338K 0.17% 13
2023
Q4 		$270K Buy
+6,690
New +$196K 0.1% 32
2023
Q3 		– Sell
-4,543
Closed -$131K – 437
2023
Q2 		$131K Buy
+4,543
New +$101K 0.12% 73

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Counterpoint Mutual Funds's RXST Position: Q3 2024 in Review

Counterpoint Mutual Funds sold out of RxSight (RXST) in Q3 2024, closing a stake of 3,647 shares — an estimated $219K sold.

Counterpoint Mutual Funds first reported a position in RXST in Q2 2023 and held it in 4 quarters. The position peaked at $700K in Q1 2024. 214 funds tracked by Wall St. Rank hold RXST as of Q3 2024.

  • Counterpoint Mutual Funds reported no remaining RxSight position as of Q3 2024 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 3,647 RxSight shares in Q3 2024, an estimated $219K.
  • Counterpoint Mutual Funds first reported a position in RxSight in Q2 2023 and held it in 4 quarters.
  • Counterpoint Mutual Funds's RxSight position peaked at $700K in Q1 2024.
  • 214 funds tracked by Wall St. Rank held RxSight as of Q3 2024.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2024, filed 12 Nov 2024.